ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
2020 ESMO Updates in mCRPC: What Does the PROfound Trial Suggest for PARPi in BRCA/ATM Mutated Disease? Should We Look for Germline Events Upfront? Should DRD+ Patients Be Exposed to PARPi or Platinum Agent?
Login to view comments.
Click here to Login
